Research suggests that muscle lossas indicated by decreases in fat-free mass (which includes muscle as well as bones, water, and organs)with the medications ranges from 25% to 39% of total weight loss throughout 36 to 72 weeks, according to a 2024 study
Ipamorelin produces no significant ACTH or cortisol elevation even at 200+ fold its GH ED
A meta-analysis of seven studies including 1,757 participants with type 2 diabetes found that SGLT2 inhibitor therapy in combination with blood pressure medications (known as renin-angiotensin system blockers) was well-tolerated and resulted in greater improvement in blood pressure, glucose control, body weight, and indices of kidney function compared with the blood pressure drugs alone (Tian 2021)
Treatment with FOXO4-DRI led to the nuclear exclusion of active Ser15-phospho-p53 in senescent cells
QSYMIA can cause mood disorders, including depression and anxiety, as well as insomnia
Trademark Information: BetaPower is a registered trademark of Danisco USA, Inc., Bio-Enhanced Na-RALA is a registered trademark of GeroNova, Inc., BIOSINT is a trademark of Sigma-Tau HealthScience USA., Setria is a registered trademark of Kyowa Hakko Bio Co., Ltd